Animal Vaccines Market with Potential Impact of Coronavirus (COVID19) & Trends That Will Drive Success

 Market Insight

The global animal vaccines market is experiencing a robust growth at a CAGR of 5.65% over the forecast period with the increasing activities of dog adoption across the world. Earlier, the market held a valuation of USD 6339 million in 2017, which is now projected to increase by the assessment period. Since its valuation in 2017, it has motivated the healthcare industry extensively and is currently eyeing for impressive market growth in the forecast period, as reported by Market Research Future in an intense study.

Animal vaccines are referred to medication that controls the transmission of diseases and providing protection to animal and human health. Most commonly, veterinary vaccines for animals include rabies vaccines, foot & mouth diseases vaccines, and equine influenza virus vaccines. These prevent the transmission of infectious disease to other animals as well as humans. 

Request Sample Copy:

https://www.marketresearchfuture.com/sample_request/7184

Market Drivers & Trends

The global animal vaccines market is basking well through the attention from rising pert adoption and awareness of animal-related diseases, which is supporting the market growth substantially. The market players are also actively working to introduce more advances vaccines in the market such as in 2015, Boehringer Ingelheim launched two new swine vaccines against Porcine Reproductive and Respiratory Syndrome (PRRS), i.e., Ingelvac PRRSFLEX EU for piglets and ReproCyc PRRS EU for breeding gilts. Such factors are constantly driving the market to grow at a steady pace. 

The study further incorporates factors behind the global animal vaccine market growth such as increasing incidence of livestock diseases, technological advancements, increasing adoption of companion animals as well as rising government initiative towards vaccination updates are driving the growth of the global animal vaccine market.

Market Segmentation

The global animal vaccines market has been categorized into type, technology, indications, composition.

By type: static porcine vaccines, poultry vaccines, livestock vaccines, companion animal vaccines, aquaculture vaccines, and others are the segments. Livestock vaccines is also sub-segmented into bovine vaccines, and small ruminant vaccines, canine vaccines, and feline vaccines.

By technology: live attenuated vaccines, inactivated vaccines, toxoid vaccines, recombinant vaccines, and others are the segments.

By indications: foot & mouth disease, parvovirus, distemper, reproductive & respiratory syndrome, and others are the segments.

By composition: mono vaccine and combination vaccines are the segments.

Regional Outlook

In the current study, the segmentation of the global animal vaccination has been covered in the regions of the Americas, Europe, Asia-Pacific, and the Middle East & African. Among these, the Americas are the leaders of the market share due to the presence of significant market players, activities of rising pet adoption in developed countries such as the US and Canada. In this, according to the American Society for the Prevention of Cruelty to Animals (ASPCA), approximately 6.5 million companion animals enter the US animal shelters nationwide every year.

Europe region was positioned second in the market share in 2017, due to the rising research and development investments. In the latest, this region is also gaining a considerable amount of traction due to a vast number of pet lovers residing and their awareness towards vaccination module. In this support, in 2018, Boehringer Ingelheim announced to reinforce its leading position in the veterinary vaccine market with an investment of 70 million euro in the R&D and biological production activities.

Key players

Bayer AG, Biogenesis Bago, Boehringer Ingelheim GmbH, China Animal Husbandry, Elanco Animal Health, Hester, IDT Biologika, Indian Immunologicals Limited, Merck Animal Health, MSD Animal Health, Phibro Animal Health, Tianjin Ringpu, Vetoquinol, Zoetis Inc., and others are some of the vital players in the global animal vaccines market. 

Browse Complete Report with TOC at

https://www.marketresearchfuture.com/reports/animal-vaccines-market-7184

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

Comments

Post a Comment

Popular posts from this blog

Cosmetic Dentistry Market Size By Application, Growth Potential, Price Trend & Forecast

  Market Highlights Cosmetic dentistry is the dental work that helps improve the look of a person's teeth. The treatment includes teeth whitening, straightening, reshaping, and realignment. There are several other cosmetic dental services, which include cosmetic gum surgery, tooth contouring and reshaping, tooth colored fillings, composite bonding, dental implants, and inlays and onlays. Technological advancements have also allowed the application of novel techniques. The high cost of dental imaging procedures and lack of reimbursement options hinder the growth of this market. The global cosmetic dentistry market is dominated by many key market players. These players are engaged in new product launches and tactical partnerships to brace their market position. For instance, in April 2017, Zimmer Biomet Holdings, Inc. announced the distribution of NovaBone Dental Putty in over 40 countries within the Middle East, Africa, Latin America, Asia-Pacific, and the selected markets in Europe
Read more

Brucellosis Treatment Market Insights by Trends, Growth, Scope, Size, Overall Analysis and Prognostication

  Market Highlights: Brucellosis is a zoonotic infection caused by the species of Brucella bacteria. The bacteria is transmitted from animals to humans through infected food products, direct contact with an infected animal, or inhalation of aerosols. The disease is known by many names, including Mediterranean fever, Malta fever, gastric remittent fever, and undulant fever. Usually, humans are accidental hosts, but brucellosis still continues to remain a major health concern worldwide. Brucellosis is a has a high degree of morbidity in humans worldwide. According to WHO data about 500,000 cases of this disease are registered in the world every year. Request Sample Copy: https://www.marketresearchfuture.com/sample_request/5159 Usually, Brucella abortus is associated with the disease in cattle and bison, Brucella suis with the disease in swine, and Brucella melitensis with the disease in sheep and goats. Under appropriate conditions, brucellosis can be caused in one species b
Read more

Preclinical Imaging Market Dynamics, Developments, Potential Players & Worldwide Opportunities

  The global preclinical imaging market is growing pervasively, witnessing increasing consumption of imaging products in various modalities. Also, rising technological advances in the field of molecular imaging, alongside the growing demand for non-invasive small animal imaging techniques drives the growth of the market. Moreover, increasing funding to support preclinical researches is escalating the market growth to furthered height.  Request Sample Copy: https://www.marketresearchfuture.com/sample_request/7365 According to Market Research Future (MRFR), the global preclinical imaging market valuation had reached USD 2.01 BN in 2017, which is further expected to appreciate at 6.3% CAGR over the assessment period (2018 to 2023). The market has seen several innovative and easy-to-use imaging agents launches, which has undoubtedly helped in the growth of the market. Rising technological advancements are estimated to propel the growth of the market.  The growing prevalence of myriads of c
Read more